MarketPeel
Insider Trading Intelligence
RK

Robb Knie

HOTH
CEO AND PRESIDENT · HOTH THERAPEUTICS, INC. · CIK 0001609695
FILING MIX · LIFETIME92%/8%
BUYS
12
SELLS
1
TOTAL VALUE
$400.7K
COMPANIES
1
ACTIVE SINCE
Jul 2020
HOLDINGS NOW
547,387
AVG SELL PX
$1.21
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robb Knie, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%-0.74%-3.13%+2.39%+1.92%
14d3+0.00%-8.79%-3.77%-5.02%-3.13%
30d3+33.33%+4.60%-2.83%+7.43%-8.16%
60d3+33.33%-31.24%+3.40%-34.64%-61.90%
90d3+33.33%-35.32%+2.23%-37.55%-57.73%
180d3+33.33%-33.62%+4.07%-37.69%-77.12%
1y3+33.33%-27.30%+16.57%-43.87%-97.69%
2y3(1 pending)+0.00%-89.53%+49.06%-138.59%-138.59%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HOTH · 547,387 shares · as of Aug 28, 2025
0214,533429,066643,598858,13120212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
FLOW · 12 buys / 1 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HOTH
HOTH THERAPEUTICS, INC.
SALE
CEO and President
310,744$1.21$376.0K547,387Aug 28, 2025Aug 28, 2025View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
800,000858,131Aug 27, 2025Aug 28, 2025View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,0007,000Jan 14, 2025Jan 15, 2025View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
93,00093,000Jan 14, 2025Jan 15, 2025View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
325,000325,000Aug 19, 2024Aug 21, 2024View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASE
CEO and President
25,000$0.67$16.8K58,131Aug 16, 2024Aug 19, 2024View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
225,000225,000Jan 5, 2024Jan 8, 2024View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jul 17, 2023Jul 18, 2023View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASE
CEO and President
10,000$0.39$3.9K828,259Sep 19, 2022Sep 20, 2022View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASE
CEO and President
10,000$0.40$4.0K818,259Sep 16, 2022Sep 19, 2022View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
500,000500,000Mar 16, 2022Mar 18, 2022View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
225,000225,000Jan 29, 2021Feb 1, 2021View →
HOTH
HOTH THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,00080,000Jul 21, 2020Jul 23, 2020View →
Other insiders · HOTH
Loading peer insiders…
About this filer
CIK 0001609695
ROLE
CEO and President
PRIMARY
HOTH
COMPANIES
1
ACTIVE SINCE
Jul 2020
MARKETPEEL · /INSIDER/0001609695DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback